William Paul Glezen

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Influenza vaccination for healthy children
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Curr Opin Infect Dis 15:283-7. 2002
  2. ncbi Impact of respiratory virus infections on persons with chronic underlying conditions
    W P Glezen
    Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Tex 77030, USA
    JAMA 283:499-505. 2000
  3. ncbi A response to strategy #2: streamlining the regulatory process
    W Paul Glezen
    Influenza Research Center, Department of Molecular Virology, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Infect Dis 42:S141-4. 2006
  4. ncbi Modifying clinical practices to manage influenza in children effectively
    William Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, USA
    Pediatr Infect Dis J 27:738-43. 2008
  5. ncbi Control of influenza
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Tex Heart Inst J 31:39-41. 2004
  6. ncbi Cold-adapted, live attenuated influenza vaccine
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030 3498, USA
    Expert Rev Vaccines 3:131-9. 2004
  7. ncbi Session IV. Ethical, liability and regulatory issues
    W Paul Glezen
    Molecular Virology, Microbiology and Pediatric Influenza Research Center, Baylor College of Medicine, One Baylor Plaza Suite 221 D, Houston, TX 77030, USA
    Vaccine 21:3501-2. 2003
  8. ncbi Effect of maternal antibodies on the infant immune response
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030, USA
    Vaccine 21:3389-92. 2003
  9. ncbi Influenza virus in pediatric patients. Introduction
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM-240, Houston, TX 77030-3498, USA
    Semin Pediatr Infect Dis 13:69-70. 2002
  10. ncbi Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections
    W P Glezen
    Molecular Virology and Microbiology, Influenza Research Center at Baylor College of Medicine, One Baylor Plaza, Suite 221D, Houston, TX 77030, USA
    Vaccine 19:S56-8. 2000

Collaborators

Detail Information

Publications26

  1. ncbi Influenza vaccination for healthy children
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Curr Opin Infect Dis 15:283-7. 2002
    ..The new live attenuated nasal spray influenza vaccine is particularly effective in healthy children who would benefit most from universal immunization...
  2. ncbi Impact of respiratory virus infections on persons with chronic underlying conditions
    W P Glezen
    Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Tex 77030, USA
    JAMA 283:499-505. 2000
    ..Development of new approaches for prevention of acute respiratory tract conditions requires studies of the etiologies of infections and quantification of the risk of hospitalization for vulnerable patients...
  3. ncbi A response to strategy #2: streamlining the regulatory process
    W Paul Glezen
    Influenza Research Center, Department of Molecular Virology, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Infect Dis 42:S141-4. 2006
    ..Regulatory bodies must work with manufacturers to facilitate implementation of new production practices, to ensure steady expansion of the supply of safe and effective vaccines...
  4. ncbi Modifying clinical practices to manage influenza in children effectively
    William Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, USA
    Pediatr Infect Dis J 27:738-43. 2008
    ..The neuraminidase inhibitors also have shown efficacy against influenza B infection and exhibit less viral resistance than the older adamantane antiviral class...
  5. ncbi Control of influenza
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 3498, USA
    Tex Heart Inst J 31:39-41. 2004
    ..The availability of the live, attenuated, cold-adapted nasal spray vaccine should facilitate this goal...
  6. ncbi Cold-adapted, live attenuated influenza vaccine
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030 3498, USA
    Expert Rev Vaccines 3:131-9. 2004
    ..Use of CAIV-T in children will not only decrease the risk of serious disease, but also dampen the spread of the virus in the community and reduce exposure of patients who are at high risk of complications and death...
  7. ncbi Session IV. Ethical, liability and regulatory issues
    W Paul Glezen
    Molecular Virology, Microbiology and Pediatric Influenza Research Center, Baylor College of Medicine, One Baylor Plaza Suite 221 D, Houston, TX 77030, USA
    Vaccine 21:3501-2. 2003
  8. ncbi Effect of maternal antibodies on the infant immune response
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM 280, Houston, TX 77030, USA
    Vaccine 21:3389-92. 2003
    ..No evidence for the development of fetal tolerance after immunization during pregnancy has occurred subsequently in infants following active vaccination...
  9. ncbi Influenza virus in pediatric patients. Introduction
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM-240, Houston, TX 77030-3498, USA
    Semin Pediatr Infect Dis 13:69-70. 2002
  10. ncbi Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections
    W P Glezen
    Molecular Virology and Microbiology, Influenza Research Center at Baylor College of Medicine, One Baylor Plaza, Suite 221D, Houston, TX 77030, USA
    Vaccine 19:S56-8. 2000
    ..Influenza produces high morbidity in children that could be averted by universal immunization with attenuated nasal spray vaccine...
  11. ncbi The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures
    W Paul Glezen
    Departments of Molecular Virology and Microbiology and of Pediatrics, Baylor College of Medicine, Houston, TX, USA
    Pediatr Infect Dis J 23:S202-6. 2004
    ..New approaches to control will be necessary to reduce impact of these infections. These include earlier availability of influenza vaccine each autumn and use of antivirals and new vaccines for RSV...
  12. ncbi Universal influenza vaccination and live attenuated influenza vaccination of children
    W Paul Glezen
    Department of MVM, Baylor College of Medicine, Houston, TX 77030, USA
    Pediatr Infect Dis J 27:S104-9. 2008
    ..Systematic delivery of influenza vaccine in school-based and workplace-based clinics would greatly enhance the control of epidemic influenza and help prepare for the next pandemic...
  13. ncbi Improving influenza immunization in pregnant women and healthcare workers
    Melanie E Mouzoon
    Kelsey Seybold Clinic, Houston, TX, USA
    Am J Manag Care 16:209-16. 2010
    ..To evaluate the effect of several strategies to increase influenza immunization in a multispecialty clinic...
  14. ncbi Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children
    Pedro A Piedra
    Baylor College of Medicine, Department of Molecular Virology and Microbiology, Room 248E, One Baylor Plaza, Houston, TX 77030, USA
    Pediatrics 120:e553-64. 2007
    ..The objective of this study was to determine the effectiveness of influenza vaccines for healthy school-aged children when administered during the influenza outbreak...
  15. ncbi Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatrics 116:e397-407. 2005
    ....
  16. ncbi Safety of influenza vaccination during pregnancy
    Flor M Munoz
    Baylor College of Medicine, Department of Pediatrics and Molecular Virology, Houston, TX 77030, USA
    Am J Obstet Gynecol 192:1098-106. 2005
    ..The purpose of this study was to evaluate the safety of influenza vaccine that is administered in the second or third trimester of gestation...
  17. ncbi Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
    Flor M Munoz
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Influenza Reseach Center, One Baylor Plaza Suite 221 D, MS BCM 280, Houston, TX 77030, USA
    Vaccine 21:3465-7. 2003
    ..infants of placebo recipients. Vaccine specific anti-F IgA and IgG concentrations in breast milk were higher in mothers who received RSV-PFP-2...
  18. ncbi Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 202:1626-33. 2010
    ..This field trial examines the effectiveness of school-based clinics for vaccine delivery before an epidemic caused by 3 new influenza virus variants not contained in the vaccine...
  19. ncbi Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX, USA
    Vaccine 21:3479-82. 2003
    ..To determine if respiratory syncytial virus (RSV) specific, serum antibody titers correlate with protection against RSV associated-hospitalization at all ages...
  20. ncbi Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children
    Pedro A Piedra
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Rm 248E, One Baylor Plaza, Houston, TX 77030, USA
    Vaccine 23:1540-8. 2005
    ..Vaccination of approximately 20-25% of children, 1.5-18 years of age in the intervention communities resulted in an indirect protection of 8-18% against MAARI in adults > or =35 years of age...
  21. ncbi Asthma, influenza, and vaccination
    W Paul Glezen
    Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
    J Allergy Clin Immunol 118:1199-206; quiz 1207-8. 2006
    ..Universal vaccination of all children in school-based clinics will facilitate control of epidemic influenza and provide an infrastructure for control of future influenza pandemics...
  22. ncbi Herd protection against influenza
    W Paul Glezen
    MVM Department, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX 77030, United States
    J Clin Virol 37:237-43. 2006
    ..School-based clinics could provide a platform for rapid deployment of vaccine accessible to all segments of the population. This strategy could be critical for control of pandemic influenza...
  23. ncbi Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus
    Ladonna K Hite
    Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Infect Dis 11:40-7. 2007
    ..During the 2002-2003 season, a new variant of influenza B co-circulated with influenza A viruses. This study examines the characteristics and outcomes of children with influenza A and B virus infection vs. other acute respiratory illnesses...
  24. ncbi Commentary: benefits of influenza vaccine in US elderly--new studies raise questions
    W Paul Glezen
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    Int J Epidemiol 35:352-3. 2006
  25. ncbi New vaccines for old diseases: trivalent cold-adapted influenza vaccine
    W Paul Glezen
    Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030-3498, USA
    Pediatr Ann 33:545-50. 2004
    ..The number of excess deaths is expected to double within the next 25 years if control methods are not intensified. CAIV-T may become an important adjunct to control measures and can facilitate influenza pandemic preparedness...
  26. ncbi Respiratory viral infections in patients with chronic, obstructive pulmonary disease
    J David Beckham
    Department of Medicine, Baylor College of Medicine and Ben Taub General Hospital, One Baylor Plaza, Houston, TX 77030, USA
    J Infect 50:322-30. 2005
    ..CONCLUSIONS: Respiratory viral infections are commonly associated with acute respiratory illness in COPD patients, and the use of RT-PCR assays significantly increases the ability to diagnose these infections...